Selecting the Best CyberKnife Centres and Specialists in India for Australian Patients

Author:- Dr. Dheeraj Bojwani Date Created:- 14-08-2026

Most Australians should never need this guide, and I want to say that plainly before anything else. Australian radiation oncology is genuinely excellent, close to free at the point of use through Medicare, and conventional treatment remains entirely appropriate for most tumours. This guide exists for a narrower group — and it is worth being precise about who that is before a single criterion is discussed. In 24 years of guiding international patients into Indian hospitals, I have turned away more people asking specifically for CyberKnife than for almost any other named technology, precisely because it is so often the wrong question. The right question is always whether your specific tumour is a genuine candidate. If none of the four reasons above describes your situation, the right next step is a conversation with your Australian radiation oncologist, not this document.

Healing Journeys of Australian Patients

Australian Patients Share Their Experience

Key Takeaways

• The guide explains that CyberKnife is a robotic stereotactic radiosurgery system used for selected tumours without conventional surgery. It stresses that treatment suitability must be confirmed before choosing a CyberKnife centre, with honest candidacy assessment given the highest selection weight.
• It covers selected brain, spine, lung and liver tumours, noting that treatment requirements vary according to tumour location. For moving tumours, particularly selected lung and liver lesions, appropriate motion-tracking technology should be confirmed.
• The guide highlights the importance of a radiation oncologist experienced in stereotactic radiosurgery and a qualified medical physicist for treatment planning, dose calculation and quality assurance. Patients should also verify multidisciplinary review and the centre's specific CyberKnife experience.
• Australian patients are advised to review their imaging and medical records with the treating specialist before travelling. They should also confirm the treatment plan, quotation, follow-up schedule and arrangements for sharing treatment and dose information with their Australian oncology team.
• The guide also highlights the importance of patient-specific treatment planning and quality assurance, rather than choosing a centre simply because it has CyberKnife technology. Australian patients should verify the specialist's experience, the involvement of medical physics and whether the centre can provide the required technology for their particular tumour.
• It identifies several warning signs, including unclear treatment suitability, vague claims about CyberKnife experience and insufficient information about motion management or treatment planning. Before travelling to India, Australian patients should also confirm their follow-up arrangements and ensure that complete treatment records can be shared with their Australian oncology team.

Quick Facts

Treatment

CyberKnife Stereotactic Radiosurgery

Country

India

Intended Patients

Australian Patients

Treatment Type

Non-Invasive Robotic Radiosurgery

Key Requirement

Confirm CyberKnife Candidacy

Main Applications

Selected Brain, Spine, Lung and Liver Tumours

Key Specialist

Radiation Oncologist

Specialist Expertise

Stereotactic Radiosurgery Experience

Technical Specialist

Medical Physicist

Important Technology

Image Guidance and Motion Tracking

Motion Management

Particularly Important for Moving Tumours

Treatment Planning

Patient-Specific Planning

Quality Assurance

Medical Physics and Treatment Verification

Treatment Sessions

Usually Delivered in a Small Number of Sessions

Hospital Review

Multidisciplinary Assessment

Important Check

Tumour Size, Location and Previous Treatment

Warning Signs

Unclear Candidacy or Vague CyberKnife Experience

Follow-Up

Australian Radiation Oncologist

Required Records

Imaging, Diagnosis, Treatment Plan and Dose Information

Pre-Travel Check

Confirm Treatment Plan and Itemised Quotation

Accreditation

JCI or NABH

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

In Brief

For Australian patients considering CyberKnife treatment in India, the guide recommends beginning with clinical suitability rather than technology selection. CyberKnife may be useful for selected tumours, but the appropriate approach depends on tumour location, size, movement, previous treatment and nearby critical structures. The guide therefore places considerable importance on specialist radiation oncology experience, medical physics, patient-specific treatment planning and motion management where required. It also recommends multidisciplinary review before treatment and a clear follow-up arrangement with the Australian oncology team. Australian patients should obtain their imaging and treatment records in full and avoid making decisions based solely on claims of faster treatment or advanced technology.

Before you choose anyone: understand what this technology actually is

CyberKnife is a robotic radiosurgery system that delivers highly precise, high-dose radiation from thousands of possible angles, guided continuously by real-time imaging. Despite the name, nothing is cut; it is radiation therapy, not surgery, delivered with sub-millimetre accuracy. This makes it valuable for tumours difficult or dangerous to reach surgically, but it is not a universal upgrade over conventional treatment, and treating it as one is the single most common mistake patients make researching this technology. Conventional radiotherapy, delivered by an experienced Australian oncologist, remains excellent and entirely appropriate for the great majority of tumours. This guide is written to help you ask the right question of whoever proposes this specific technology, wherever you are being treated, rather than to persuade you it is the answer.

Get your full imaging and a written note on what your Australian radiation oncologist has said about your specific candidacy before your first overseas conversation.

Part one: judging the team

1. Honest candidacy assessment, not a default recommendation. This is the single heaviest criterion in this guide. Small, well-defined tumours in the brain or spine are generally good candidates; tumours in the lung or liver require confirmed real-time motion tracking; very large or widely spread tumours are usually not appropriate at all. A radiation oncologist, not a sales conversation, should be making this determination.

2. A named medical physicist on every treatment plan. CyberKnife planning is a genuinely technical, physics-driven process. Ask specifically who performs patient-specific quality assurance for your treatment, and confirm this is documented, not assumed.

3. Confirmed real-time motion tracking, where relevant. If your tumour is in the lung, liver or another location that moves with breathing, ask specifically whether the system tracks and adjusts for that motion during treatment, not just whether the hospital owns a CyberKnife machine.

4. The radiation oncologist reviews your actual imaging. Insist on this happening before any recommendation, not after a quote has already been discussed.

5. Volume in your specific tumour type and location. Ask how many cases similar to yours, in tumour type and anatomical location, the centre has treated. A centre with genuinely high volume in your specific presentation has typically refined its planning and treatment protocols in ways that matter directly to your outcome, distinct from broad experience with the technology across many different, less comparable cases.

Part two: judging the hospital

6. Patient-specific quality assurance, documented. Ask to see how this process is recorded for each patient, not simply told it happens.

7. Multidisciplinary tumour board review. Ask whether your case will be reviewed by a genuine team before treatment is finalised, not decided by one clinician alone.

8. A follow-up imaging schedule arranged before you leave. CyberKnife's results take weeks to months to fully assess, unlike surgery. Confirm the specific schedule before you travel home.

9. Accreditation you can verify yourself. JCI is the international arm of the body accrediting hospitals across the United States; NABH is India's national equivalent, recognised by the same global standards authority.

10. A record your Australian oncologist can use. Before you leave you should hold the full treatment plan, dose delivered, and the specific follow-up imaging schedule.

What the quote should say, and what it usually omits

In 24 years I have found that disputes almost never concern the quoted price. They concern what the quote silently omitted.

Insist on a written, itemised figure that states exactly how many sessions are included and what happens if additional planning imaging is needed. Understand what does not travel with you: Medicare pays nothing for treatment overseas, your health fund rebate applies to Australian admissions, and standard travel insurance excludes planned treatment. Pay a deposit to secure the date, never the full balance in advance.

Four Signals that Should Make You Pause

1. CyberKnife recommended for a tumour an Australian radiation oncologist has called unsuitable. Get a second, independent opinion before proceeding.

2. No mention of motion tracking for a lung or liver tumour. This is a specific technical requirement, not an assumption you should make.

3. Marketing that describes CyberKnife as surgery, or implies zero risk. It is a real medical treatment with real, if generally milder, side effects.

4. No named medical physicist involved in your treatment plan. This role is central to the technology working safely and accurately.

Australia-specific considerations most patients miss

Tell your Australian radiation oncologist early, not after the fact. Most are more sympathetic to a second opinion than patients expect, and a team informed from the outset is better placed to arrange your follow-up.

Arrange your ongoing follow-up imaging before you leave. Confirm your Australian team is willing to review results from treatment performed overseas.

Send the imaging, not just the report. A genuine candidacy assessment requires the actual scans.

Ask about the Medical Treatment Overseas Program. Where this technology is genuinely unavailable in Australia for your specific situation, this Commonwealth programme can in some circumstances fund treatment abroad.

Apply for both visas together. Australian passport holders are eligible for India's electronic medical visa, with an e-medical attendant visa for whoever travels with you.

Ask what happens if follow-up imaging shows the tumour hasn't responded. Establish this plan before you travel, and ask an Australian oncologist the parallel question directly.

The Questions, in the Order You Should Ask Them

A closing word

CyberKnife rewards exactly the same discipline as everything else in this series: confirm you are a genuine candidate before anything else, then choose a team with real physics expertise and, where relevant, genuine motion-tracking capability. If your situation is an inoperable tumour, confirmed motion tracking, a faster pathway or re-irradiation — verify candidacy first, weight the physicist and honest assessment as heavily as anything else. If you have imaging you would like reviewed, send it and I will look at it properly — including telling you this technology isn't right for your tumour, which is an answer I give often.

Frequently Asked Questions by Australians about CyberKnife Centres and Specialists in India

Is CyberKnife suitable for every Australian patient with a brain tumour?

No. The guide explains that CyberKnife is not automatically appropriate for every brain tumour. Australian patients should have their imaging, diagnosis and tumour characteristics reviewed by an appropriately trained radiation oncology team before treatment is recommended.

Can Australian patients obtain a CyberKnife second opinion in India?

Yes. Australian patients can provide their medical records and imaging for specialist review in India. The guide recommends confirming whether CyberKnife is clinically appropriate before making travel or treatment arrangements.

Which specialist should Australian patients look for when considering CyberKnife in India?

Australian patients should look for a radiation oncologist with specific stereotactic radiosurgery experience. The guide also stresses the importance of qualified medical physics support for treatment planning, dose calculation and quality assurance.

Can Australian patients receive CyberKnife for lung tumours in India?

Selected lung tumours may be considered for stereotactic treatment. Australian patients should ask whether the centre has appropriate motion-management and image-guidance capabilities for a tumour that may move with breathing.

Can CyberKnife be used for liver tumours for Australian patients travelling to India?

Selected liver tumours may be considered for CyberKnife depending on their size, location, movement and relationship to surrounding organs. The decision should be made after individual imaging and specialist assessment.

How many treatment sessions may Australian patients need with CyberKnife?

The guide describes CyberKnife as a treatment that can be delivered in a small number of sessions, depending on the tumour and treatment plan. Australian patients should ask for the exact number of planned sessions before travelling.

Why is a medical physicist important when Australian patients choose a CyberKnife centre?

The medical physicist is involved in patient-specific treatment planning, dose calculations and quality assurance. Australian patients should ask who is responsible for these technical aspects of their treatment.

What should Australian patients check about motion tracking?

Patients with tumours that may move during breathing should ask whether the centre has suitable real-time motion-tracking technology and how movement is accounted for during radiation delivery.

What should Australian patients check before accepting a CyberKnife quotation from India?

They should first confirm that CyberKnife is appropriate for their tumour and obtain a written treatment plan and itemised quotation. The quotation should make clear what planning, treatment and follow-up services are included.

How should Australian patients arrange follow-up after CyberKnife treatment in India?

Australian patients should involve their Australian radiation oncologist before travelling and return with the complete treatment plan, dose information and recommended imaging schedule. This allows follow-up to continue with the Australian oncology team.

Sources

• Published stereotactic radiosurgery literature on candidacy, motion management and outcomes — pubmed.ncbi.nlm.nih.gov
• National Medical Commission, recognised postgraduate medical qualifications in radiation oncology — nmc.org.in
• Australian Government Medical Treatment Overseas Program, eligibility criteria — health.gov.au
• Joint Commission International, accreditation registers — jointcommissioninternational.org
• National Accreditation Board for Hospitals & Healthcare Providers, accreditation registers — nabh.co
• High Commission of India, e-Visa categories and eligibility — indianvisaonline.gov.in

Page Summary

This guide helps Australian patients understand when CyberKnife treatment in India may be appropriate for their specific tumour. It explains why treatment suitability should be established before selecting a CyberKnife centre or specialist. The guide highlights radiation oncology expertise, stereotactic treatment experience, medical physics and motion tracking where required. It also covers treatment planning, quality assurance, multidisciplinary review and follow-up arrangements. Warning signs help patients identify centres that may not provide sufficient information about treatment suitability or technical planning. The final section outlines the pathway from medical records and specialist consultation to treatment and continued follow-up in Australia.

Citation Block

Field	Information
Topic Information	Selecting the Best CyberKnife Centres and Specialists in India for Australian Patients
Treatment	CyberKnife Stereotactic Radiosurgery
Country	India
Intended Audience	Australian Patients
Treatment Type	Robotic Stereotactic Radiosurgery
Key Selection Criterion	Honest CyberKnife Candidacy Assessment
Main Applications	Selected Brain, Spine, Lung and Liver Tumours
Key Specialist	Radiation Oncologist
Specialist Expertise	Stereotactic Radiosurgery
Technical Specialist	Medical Physicist
Important Technology	Image Guidance and Motion Tracking
Motion Management	Required Where Tumour Movement Is Relevant
Treatment Planning	Patient-Specific Treatment Planning
Quality Assurance	Medical Physics and Treatment Verification
Hospital Review	Multidisciplinary Assessment
Important Assessment	Tumour Type, Size, Location and Previous Treatment
Warning Signs	Unclear Candidacy, Vague Experience or Inadequate Planning Information
Treatment Timeline	Depends on Individual Treatment Plan
Follow-Up	Australian Radiation Oncologist
Required Records	Imaging, Diagnosis, Treatment Plan and Dose Information
Pre-Travel Check	Confirm Candidacy, Treatment Plan and Quotation
Accreditation	JCI or NABH
Australian Coordination	Share Treatment Records with the Local Oncology Team